Conference Description
The Cancer Nanotechnology GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Cancer nanotechnology is the engineering of nanoscale materials that aim to revolutionize the diagnosis, treatment, prevention, and study of cancer. Since its inception, cancer nanotechnology research has produced multiple diagnostics and therapies that are making an impact on patients. The 2025 Cancer Nanotechnology GRC will discuss current efforts to produce personalized nanomedicines, immunotherapeutic nanoparticles, diagnostic imaging and sensing platforms, and research tools, to further improve patient outcomes. The 2025 Cancer Nanotechnology GRC, and the associated trainee-focused GRS, will bring together exceptional scientists and clinicians to: 1) share cutting-edge research in cancer nanotechnology; 2) foster discussion, exchange of ideas, and promote collaborations in a collegial and supportive environment, and; 3) enhance the training and development of young scientists while also promoting diversity and inclusion.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by February 15, 2025. Please check back for updates.
Perspectives on Nanomedicine Translation
Discussion Leaders
-
Dan Peer (Tel Aviv University, Israel)
Speakers
-
Vinod Balachandran (Memorial Sloan Kettering Cancer Center, United States)
-
Pieter Cullis (UBC, Canada)
Nucleic Acid Therapeutics
Discussion Leaders
-
Michael Mitchell (University of Pennsylvania, United States)
Speakers
-
Natalie Artzi (Harvard Medical School / Brigham and Women's Hospital, United States)
-
Angela Alexander-Bryant (Clemson University, United States)
-
Yizhou Dong (Icahn School of Medicine at Mount Sinai, United States)
-
Olivia Merkel (Ludwig Maximilian University of Munich, Germany)
Tools for Discovery in Cancer Biology and Therapeutic Targets
Discussion Leaders
-
Cesar Castro (Massachusetts General Hospital / Harvard Medical School, United States)
Speakers
-
Dal-Hee Min (Seoul National University, South Korea)
-
Molly M. Stevens (University of Oxford, United Kingdom)
Overcoming Biological Barriers to Cancer Nanomedicines
Discussion Leaders
-
Marianne Ashford (AstraZeneca UK, United Kingdom)
Speakers
-
Warren Chan (Nanyang Technological University, Singapore)
-
Cristina Fornaguera Puigvert (Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), Spain)
-
Maria J. Vicent (Prince Felipe Research Center, Spain)
Artificial Intelligence Approaches in Nanomedicine and Nanodiagnostics
Discussion Leaders
-
Luisa Russell (National Institute of Biomedical Imaging and Bioengineering, United States)
-
Tarek Fadel (MIT, United States)
Speakers
-
Daniel Reker (Duke University, United States)
-
Avi Schroeder (Technion - Israel Institute of Technology, Israel)
Cancer Immunotherapy and Microbiome Engineering
Discussion Leaders
-
Betty Kim (MD Anderson Cancer Center, United States)
Speakers
-
Yoon Yeo (Purdue University, United States)
-
Shanta Dhar (University of Miami Miller School of Medicine, United States)
-
Darrell Irvine (The Scripps Research Institute, United States)
Nanoparticle Biomimicry and Biointerfacing
Discussion Leaders
-
Assaf Zinger (Technion- Israel Institute of Technology, Israel)
Speakers
-
Chun-Xia Zhao (The University of Adelaide, Australia)
-
Zhen Gu (Zhejiang University, China)
Cancer Diagnostics and Contrast Agents
Discussion Leaders
-
Rachela Popovtzer (Bar-Ilan University, Israel)
Speakers
-
Carlos Rinaldi-Ramos (University of Florida, United States)
-
Gabriel Kwong (Georgia Tech, United States)
-
Tyrone Porter (University of Texas at Austin, United States)
-
Paolo Decuzzi (Italian Institute of Technology, United States)
Selected Talks from Poster Abstracts
Discussion Leaders
-
Christopher Alabi (Cornell University, United States)
-
John Wilson (Vanderbilt University, United States)
Speakers
The GRC Power Hour™
Organizers
-
Jessica Larsen (Clemson University, United States)
